Skip to Content
ImmunoINSIGHTS
  • Our Company
    • Mission
    • Corporate
    • Team
    • Regulatory
    • Resources
  • Science/Technology
    • What are Autoantibodies (antibodies)?
    • ImmunoINSIGHTS™ Platform
    • Autoimmune Diseases
    • Immuno-oncology
    • Infectious Diseases
    • Neurological Diseases
    • Allergy / Dermatology
    • Multiplex Serology
  • Contact

Categories for General

Oncimmune announces strategy updates and changes to the board of directors.

October 12, 2023 12:33 pm

Oncimmune receives Queen’s Award for Enterprise in Innovation 2022

April 21, 2022 9:02 am

ImmunoINSIGHTS signs contract with leading top 10 global pharmaceutical company to profile biomarkers in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (“CIDP”).

March 4, 2022 10:17 am

ImmunoINSIGHTS and Synexa Life Sciences sign go-to-market service partnership

March 1, 2022 10:22 am

‘Extra Time’ podcast. In conversation with Professor Frank Sullivan

July 30, 2020 11:36 am

Simple blood test that could spot deadly lung cancer is saving lives by detecting disease years before symptoms show

March 2, 2020 2:39 pm

Oncimmune submission to Health and Social Care Committee inquiry

January 29, 2020 2:30 pm

Has this doctor revolutionised lung cancer detection?

November 2, 2019 12:54 pm

New blood test trialled on 12,000 Scots catches lung cancer early

September 10, 2019 1:26 pm

Blood test for smokers could slash death rates from lung cancer by detecting the disease FOUR YEARS before it shows up on scans

September 9, 2019 11:11 am
ImmunoINSIGHTS

“Understanding diseases through the lens of the human immune system.”

U.S. Headquarters

Alden Scientific Holdings Incorporated
One Broadway, 14th Floor
Cambridge, MA 02142
USA

Germany

Alden Scientific Immune GmbH
Otto-Hahn-Straße 15
44227 Dortmund
Germany

  • Privacy Policy
  • Cookies Policy
  • Terms of Use
  • Imprint

© 2026 Alden Scientific Immune. Immunoinsights.co is a service offering of Alden Scientific Immune.